Last reviewed · How we verify

NCT06271226: EFFECTOFACU

The Effect of Acupressure Applied to Icu on Pain and Physiological Parameters

Status unknown NA Last updated 21 February 2024
What this trial tests

NA trial testing acupressure in Intensive Care Patients in 30 participants. Status unknown.

Timeline
20 March 2023
Primary endpoint
30 June 2024
31 December 2024

Quick facts

Lead sponsorOndokuz Mayıs University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposesupportive care
Enrollment30
Start date20 March 2023
Primary completion30 June 2024
Estimated completion31 December 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Ondokuz Mayıs University

Who can join

18 and older, any sex, with Intensive Care Patients or Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this experimental study is to determine the effect of acupressure applied to intensive care patients on pain and physiological parameters (blood pressure, heart rate, respiration and oxygen saturation). The main questions that the study aims to answer are: Acupressure applied to intensive care patients has no effect on pain. Acupressure applied to intensive care patients has an effect on pain. Acupressure applied to intensive care patients has no effect on physiological parameters. Acupressure applied to intensive care patients has an effect on physiological parameters. Participants will be included in the study after obtaining consent from patients who were treated in the intensive care unit, who scored 9 and above on the glaskow coma scale by evaluating their consciousness status, and had pain after evaluating their pain.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of acupressure

Trials testing the same drug.

Other recruiting trials for Intensive Care Patients

Currently open trials in the same condition.

Other Ondokuz Mayıs University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06271226.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing